Chemesis International Inc. acquired Viverian, a hemp-derived cannabidiol product portfolio.

The Viverian product line includes cannabidiol tinctures and capsules for improved sleep and wellness, and is being distributed in Arizona, Nevada and Florida through an online e-commerce platform.

As part of the deal, Vancouver, British Columbia-based Chemesis will pay US$500,000 in stock priced at market close Dec. 14.

The retail cannabis distributor will expand into a retail strategy and additional states for online shipping in 2019, once cannabidiol regulations are put into place.